Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells

被引:129
作者
Nerurkar, MM
Ho, NFH
Burton, PS
Vidmar, TJ
Borchardt, RT
机构
[1] PHARMACIA & UPJOHN INC, ABSORPT POTENTIAL & TRANSPORT, KALAMAZOO, MI 49001 USA
[2] PHARMACIA & UPJOHN INC, BIOSTAT PHARMACEUT DEV, KALAMAZOO, MI 49001 USA
[3] UNIV KANSAS, DEPT PHARMACEUT CHEM, LAWRENCE, KS 66047 USA
关键词
D O I
10.1021/js960483y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The transport of the model peptide Acf(NMef)(2)NH2 across Caco-2 cell monolayers was studied in the apical (AP) to basolateral (BL) and the BL to AP direction in the presence of Polysorbate 80 or Cremophore EL in the AP compartment. Increasing surfactant concentrations resulted in increasing AP-->BL peptide permeability and decreasing BL-->AP permeability. In either direction, limiting permeabilities were achieved at concentrations less than the critical micellar concentrations (cmc's) of the surfactants, and remained constant at much higher concentrations. These plateau permeabilities were not equivalent in the two directions. This residual assymetry was abolished by increasing the peptide concentration. Altogether, the observations support the presence of at least two pumps in Caco-2 cells for this peptide, polarized in the BL-->AP direction. These experimental results were analyzed within the context of a quantitative biophysical model incorporating concurrent passive diffusion across the AP and BL membranes accompanied by surfactant-inhibitable active polarized efflux across the AP membrane. The model was also used to locate the additional transport activity at the BL membrane as an uptake pump. Under conditions of complete inhibition, the intrinsic passive diffusional permeability of Acf(NMef)(2)NH2 was found to be 13 x 10(-6) cm/s, essentially identical with results reported earlier with this peptide utilizing verapamil as an inhibitor. With respect to the mechanism of surfactant inhibition of the apical efflux tranport, the monomeric species was found to be responsible with no contribution from micelles. Modeling the mode of inhibition as a noncompetitive Michaelis-Menten process gave identical K-i's of 0.5 mu M for the two surfactants. Finally, increase of either surfactant beyond 750 mu M resulted in a decrease of peptide permeability in the AP-->BL direction. This was attributed to weak association of the peptide with micelles in the AP compartment, which effectively decreased the thermodynamic activity of the peptide at surfactant concentrations greater than 20 times their cmc. Both the experimental approach and accompanying theoretical model demonstrated in this work will allow for further characterization of the inhibitory potencies of surfactants for the nonpassive efflux pathway in vitro and in vivo.
引用
收藏
页码:813 / 821
页数:9
相关论文
共 32 条
[1]   THEORETICAL AND EXPERIMENTAL STUDIES OF TRANSPORT OF MICELLE-SOLUBILIZED SOLUTES [J].
AMIDON, GE ;
HIGUCHI, WI ;
HO, NFH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (01) :77-84
[2]   INHIBITION OF ERYTHROCYTE GLUTATHIONE CONJUGATE TRANSPORT BY POLYETHOXYLATED SURFACTANTS [J].
BOARD, PG .
FEBS LETTERS, 1993, 315 (03) :298-300
[3]   EVIDENCE FOR A POLARIZED EFFLUX SYSTEM FOR PEPTIDES IN THE APICAL MEMBRANE OF CACO-2 CELLS [J].
BURTON, PS ;
CONRADI, RA ;
HILGERS, AR ;
HO, NFH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (03) :760-766
[4]   In vitro permeability of peptidomimetic drugs: The role of polarized efflux pathways as additional barriers to absorption [J].
Burton, PS ;
Goodwin, JT ;
Conradi, RA ;
Ho, NFH ;
Hilgers, AR .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :143-156
[5]   REVERSAL OF C1300 MURINE NEUROBLASTOMA MULTIDRUG-RESISTANCE BY CREMOPHOREL, A SOLVENT FOR CYCLOSPORINE-A [J].
CHERVINSKY, DS ;
BRECHER, ML ;
BAKER, RM ;
HOELCLE, MJ ;
TEBBI, CK .
CANCER BIOTHERAPY, 1993, 8 (01) :67-75
[6]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS .2. PEPTIDE-BOND MODIFICATION WHICH RESULTS IN IMPROVED PERMEABILITY [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1992, 9 (03) :435-439
[7]  
COON JS, 1991, CANCER RES, V51, P897
[8]   EXPRESSION OF THE MULTIDRUG RESISTANCE GENE-PRODUCT (P-GLYCOPROTEIN) IN HUMAN NORMAL AND TUMOR-TISSUES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
BOCCIA, J ;
CASALS, D ;
BERTINO, JR ;
MELAMED, MR .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (09) :1277-1287
[9]  
DOIGE CA, 1993, BIOCHIM BIOPHYS ACTA, V1146, P65, DOI 10.1016/0005-2736(93)90339-2
[10]   POTENTIATION OF ANTICANCER-DRUG CYTOTOXICITY BY MULTIDRUG-RESISTANCE CHEMOSENSITIZERS INVOLVES ALTERATIONS IN MEMBRANE FLUIDITY LEADING TO INCREASED MEMBRANE-PERMEABILITY [J].
DRORI, S ;
EYTAN, GD ;
ASSARAF, YG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 228 (03) :1020-1029